76 results
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
9 May 24
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
7:02am
. Nazzario brings nearly 30 years of leadership experience in drug launches for rare diseases. Most recently, he served as Senior Vice President of Sales … at BioCryst Pharmaceuticals. Previously, he held commercial leadership roles at Spark Therapeutics where he led the commercialization of Luxturna®
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
NOMINEES
CONTINUING DIRECTORS
CORPORATE GOVERNANCE AND RISK MANAGEMENT
BOARD INDEPENDENCE
BOARD LEADERSHIP STRUCTURE
BOARD COMMITTEES
RISK MANAGEMENT … at senior levels in public companies;
Financial expertise;
Experience in leadership roles in clinical and commercial-stage companies
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
10 Aug 23
Larimar Therapeutics Reports Second Quarter 2023 Operating and Financial Results
7:03am
).
In July 2023, Larimar strengthened its executive clinical leadership with the appointment of Russell “Rusty” Clayton, DO, as Chief Medical Officer
8-K
EX-99.1
iprj2lly 7tc
17 Jul 23
Larimar Therapeutics Appoints Dr. Rusty Clayton as Chief Medical Officer
4:08pm
8-K
EX-99.1
2ynr3ig yawlz
1 Jun 23
June 2023 Larimar Therapeutics Corporate Presentation
4:06pm
8-K
EX-99.2
3a3k6vo 1y
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
lai4jcj sd0o0
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
EX-99.2
9iavfy3q 9veyj
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
wz2mbf16
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
87s34niwzc1ak
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
pnc9nonbxs6edx fk
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
vdfkgtfjrgwvob04
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
wjnpiii qrq1camy9i0
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
66k atsnlgfnd4tu
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
44lkmk1l2to4
1 Jul 21
Other Events
6:11am